DataSheet_1_Infection Temperature Affects the Phenotype and Function of Chimeric Antigen Receptor T Cells Produced via Lentiviral Technology.pdf
Chimeric antigen receptor (CAR)-T cell therapy has become an important method for the treatment of hematological tumors. Lentiviruses are commonly used gene transfer vectors for preparing CAR-T cells, and the conditions for preparing CAR-T cells vary greatly. This study reported for the first time the influence of differences in infection temperature on the phenotype and function of produced CAR-T cells. Our results show that infection at 4 degrees produces the highest CAR-positive rate of T cells, infection at 37 degrees produces the fastest proliferation in CAR-T cells, and infection at 32 degrees produces CAR-T cells with the greatest proportion of naive cells and the lowest expression of immune checkpoints. Therefore, infection at 32 degrees is recommended to prepare CAR-T cells. CAR-T cells derived from infection at 32 degrees seem to have a balance between function and phenotype. Importantly, they have increased oncolytic ability. This research will help optimize the generation of CAR-T cells and improve the quality of CAR-T cell products.
History
References
- https://doi.org//10.1073/pnas.86.24.10024
- https://doi.org//10.1073/pnas.0813101106
- https://doi.org//10.1126/science.aar6711
- https://doi.org//10.1158/2159-8290.CD-12-0548
- https://doi.org//10.3390/ijms21228655
- https://doi.org//10.3390/jcm9113577
- https://doi.org//10.1038/s41571-020-0427-6
- https://doi.org//10.1007/978-1-0716-0146-4_5
- https://doi.org//10.18388/abp.2006_3311
- https://doi.org//10.1016/j.omto.2018.10.006
- https://doi.org//10.1016/j.ymben.2005.06.006
- https://doi.org//10.3389/fimmu.2019.03123
- https://doi.org//10.1056/NEJMoa1709919
- https://doi.org//10.1089/hum.1994.5.1-19
- https://doi.org//10.1097/CJI.0b013e3181ac6138
- https://doi.org//10.1073/pnas.0608138103
- https://doi.org//10.1097/CJI.0b013e318194a6e8
- https://doi.org//10.1038/sj.gt.3300373
- https://doi.org//10.3389/fimmu.2020.02028
- https://doi.org//10.1089/hgtb.2017.085
- https://doi.org//10.1038/leu.2015.247
- https://doi.org//10.1002/bit.10310
- https://doi.org//10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1
- https://doi.org//10.1002/1097-0290(20010320)72:6<592::AID-BIT1024>3.0.CO;2-J
- https://doi.org//10.1182/blood-2014-01-545020
- https://doi.org//10.1016/j.jcyt.2019.03.003
- https://doi.org//10.1016/j.immuni.2016.02.023
- https://doi.org//10.1182/blood-2010-05-286286
- https://doi.org//10.3389/fonc.2019.00767
- https://doi.org//10.1182/blood-2017-12-815548
- https://doi.org//10.1016/j.ymthe.2020.07.018
- https://doi.org//10.1182/blood.2020007748
- https://doi.org//10.3389/fimmu.2020.00482
- https://doi.org//10.1016/j.omtm.2018.11.010
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity